Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2018

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
GLP compliance:
yes
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
Study conducted in the Republic of Korea.

Test material

Constituent 1
Chemical structure
Reference substance name:
2,2'-[ethylenebis(oxymethylene)]bisoxirane
EC Number:
218-746-2
EC Name:
2,2'-[ethylenebis(oxymethylene)]bisoxirane
Cas Number:
2224-15-9
Molecular formula:
C8H14O4
IUPAC Name:
2,2'-[ethylenebis(oxymethylene)]bisoxirane
Test material form:
liquid

In vivo test system

Test animals

Species:
guinea pig
Strain:
Hartley
Sex:
male
Details on test animals and environmental conditions:
TEST ANIMALS
- Age at the start of treatment: main study: 7 weeks
- Weight at the start of treatment: main study: 409-494 g
- Housing:
quarantine-acclimation period: polycarbonate cages (for 4 days after receipt) and stainless wire mesh cages
study: stainless wire mesh cages
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: during the acclimation period, animals were observed for clinical signs once daily for 19 days (preliminary study: 5 days).

ENVIRONMENTAL CONDITIONS
- Temperature (°C): measurement value: 20.2–23.3°C, permissible range: 18.0–24.0°C
- Humidity (%): measurement value: 39.5–56.8%, permissible range: 30.0–70.0%
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal
Vehicle:
water
Concentration / amount:
12.5%
Route:
epicutaneous, occlusive
Vehicle:
water
Concentration / amount:
6.25%
Day(s)/duration:
2
Challenge
Route:
epicutaneous, occlusive
Vehicle:
water
Concentration / amount:
3.13%
Day(s)/duration:
1
No. of animals per dose:
test substance group: 20
control group: 10
Positive control substance(s):
no

Results and discussion

Positive control results:
A positive control group was not set in this study. However, for the validity of the study, a positive control study was conducted periodically using CDNB (1-Chloro-2,4-dinitrobenzene) which is a positive substance in the Maximization Test method.

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
12.5%
No. with + reactions:
6
Total no. in group:
20
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
12.5%
No. with + reactions:
9
Total no. in group:
20
Reading:
1st reading
Hours after challenge:
24
Group:
positive control
Dose level:
0.1%
No. with + reactions:
10
Total no. in group:
10
Remarks on result:
other: Not concurrent with study but conducted periodically
Reading:
2nd reading
Hours after challenge:
48
Group:
positive control
Dose level:
0.1%
No. with + reactions:
10
Total no. in group:
10
Remarks on result:
other: Not concurrent with study but conducted periodically
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
0%
No. with + reactions:
0
Total no. in group:
10
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
0%
No. with + reactions:
0
Total no. in group:
10

Any other information on results incl. tables

Dose selection for the 1st induction (intradermal):

In the preliminary study, the 2 treated animals were dead the day after intradermal induction. In these 2 animals necrosis was confirmed at 100% test substance, but skin reactions such as redness and swelling could not be observed at 50, 25, 12.5, 6.25 and 3.13% test substance. Therefore, an additional preliminary study was performed. The shoulder regions of 5 guinea pigs were clipped using electric clippers and shaved off hair using an electric shaver. Each animal was injected intradermally with 0.1 mL of the test substance at dose levels of 50, 25, 12.5, 6.25, and 3.13%.

As a result of the additional preliminary study, intense redness (score 3) with skin necrosis was observed in both animals at 50 and 25% test substances at 24 and 48 h after intradermal injection. Intense redness (score 3) was observed in both animals at 12.5 and 6.25% test substances. Redness (score 2) was observed in both animals at 3.13% test substance at 24 h after intradermal injection, and intense redness (score 3) was observed at 48 h.

In accordance with the results of the preliminary and additional preliminary studies, the dose level for the 1st induction was the highest concentration of the test

substance at which necrosis was not confirmed at the intradermal injection sites. Therefore, the dose level was selected at 12.5% test substance.

Dose selection for the 2nd induction (epicutaneous):

The dose level for the 2nd induction was the highest concentration of the test substance at which mild to moderate skin reactions were confirmed at the topical application sites. Therefore, the dose level was selected at 6.25% test substance.

Dose selection for the challenge:

The challenge dose level was selected at 3.13% test substance, the highest concentration at which skin reaction was not confirmed at the topical application sites.

Applicant's summary and conclusion

Interpretation of results:
Category 1B (indication of skin sensitising potential) based on GHS criteria
Executive summary:

This study was conducted to evaluate the skin sensitization potential of the test substance,

2,2’-[ethylenebis(oxymethylene)]bisoxirane, by Maximization Test using Hartley guinea pigs.

Test groups consisted of a test substance group (20 animals) and a control

group (10 animals). Since skin reactions were observed at the topical application sites in the

preliminary study, the induction sites of each group were not pretreated with 10% sodium

dodecyl sulfate (SDS) prior to the second induction.

Based on the result of this study, the sensitization rate of the test substance, 2,2’-

[ethylenebis(oxymethylene)]bisoxirane, was 45% and the sensitization grade was ‘Moderate’.

Therefore, it was judged that skin sensitization was produced under the conditions of this study.

In the test substance group, the 12.5% test substance was injected intradermally for the first

induction. The second induction was conducted with the 6.25% test substance occluded for 48

hours. The challenge was conducted with the 3.13% test substance and water for injection

(WFI) occluded for 24 hours. As a result, the redness (score 1-2) was observed at 3.13% test

substance challenge sites in six of twenty at 24 hours after challenge patch removal. Redness

(score 1-2) was observed in nine of twenty animals at 48 hours. The challenge sites with WFI

did not reveal any evidence of adverse skin reactions such as redness and swelling in any

animal.

In the control group, the first and second inductions with WFI, and the challenges with the

3.13% test substance and WFI were conducted. As a result of the challenge, no skin reactions

were observed in any animal.

During the observation period, no abnormality in clinical signs or body weight gain was

observed in any animal of any group.